Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             163 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Actin is where it's at Lindberg, Uno
2008
40-41 1 p. 1-
1 p.
artikel
2 Adjuvant histamine in cancer immunotherapy Hellstrand, Kristoffer
2000
40-41 1 p. 29-39
11 p.
artikel
3 Androgen-regulated gene expression in prostate cancer Trapman, Jan
1997
40-41 1 p. 29-36
8 p.
artikel
4 Aneuploidy and genetic instability in cancer Lengauer, Christoph
2005
40-41 1 p. 1-
1 p.
artikel
5 An overview of renal cell cancer: Pathology and genetics Moch, Holger
2013
40-41 1 p. 3-9
7 p.
artikel
6 Association of SV40 with human tumours Jasani, B.
2001
40-41 1 p. 49-61
13 p.
artikel
7 Assumptions of the tumor ‘escape’ hypothesis Restifo, Nicholas P
2002
40-41 1 p. 81-86
6 p.
artikel
8 Basic science aspects of prostate cancer Dorkin, Trevor J.
1997
40-41 1 p. 21-27
7 p.
artikel
9 Bcl-2 family proteins as regulators of oxidative stress Susnow, Nathan
2009
40-41 1 p. 42-49
8 p.
artikel
10 Bench to bedside and back again: Molecular mechanisms of α-catenin function and roles in tumorigenesis Benjamin, Jacqueline M.
2008
40-41 1 p. 53-64
12 p.
artikel
11 Beta-catenin signaling, liver regeneration and hepatocellular cancer: Sorting the good from the bad Nejak-Bowen, Kari Nichole
2011
40-41 1 p. 44-58
15 p.
artikel
12 Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine Molnár, Eszter Lázár
2000
40-41 1 p. 25-28
4 p.
artikel
13 Cancer immunotherapy: Are we there yet? Sredni, Benjamin
2012
40-41 1 p. 1-2
2 p.
artikel
14 Cancer-related inflammation: Common themes and therapeutic opportunities Balkwill, Frances R.
2012
40-41 1 p. 33-40
8 p.
artikel
15 Can chromosomal instability initiate tumorigenesis? Michor, Franziska
2005
40-41 1 p. 43-49
7 p.
artikel
16 Can mouse models for brain tumors inform treatment in pediatric patients? Weiss, William A
2004
40-41 1 p. 71-77
7 p.
artikel
17 Cell death in health and disease: the biology and regulation of apoptosis Bellamy, Christopher O.C.
1995
40-41 1 p. 3-16
14 p.
artikel
18 Cell–matrix adhesion complexes: Master control machinery of cell migration Lock, John G.
2008
40-41 1 p. 65-76
12 p.
artikel
19 Cellular transformation by SV40 large T antigen: interaction with host proteins Ali, Syed Hamid
2001
40-41 1 p. 15-22
8 p.
artikel
20 Centrosomal amplification and spindle multipolarity in cancer cells Saunders, William
2005
40-41 1 p. 25-32
8 p.
artikel
21 Chronic inflammation, immunosuppression and cancer: New insights and outlook Baniyash, Michal
2006
40-41 1 p. 80-88
9 p.
artikel
22 Clinical applications of genetic rearrangements in cancer Sheer, Denise
1996
40-41 1 p. 25-32
8 p.
artikel
23 Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer Giuriato, Sylvie
2004
40-41 1 p. 3-11
9 p.
artikel
24 Connecting mitotic instability and chromosome aberrations in cancer—can telomeres bridge the gap? Gisselsson, David
2005
40-41 1 p. 13-23
11 p.
artikel
25 Current and future systemic treatments for renal cell carcinoma Fisher, Rosalie
2013
40-41 1 p. 38-45
8 p.
artikel
26 Defective death receptor signaling as a cause of tumor immune escape French, Lars E
2002
40-41 1 p. 51-55
5 p.
artikel
27 Deregulated degradation of the cdk inhibitor p27 and malignant transformation Bloom, Joanna
2003
40-41 1 p. 41-47
7 p.
artikel
28 Drug discovery in the p53 field Lain, Sonia
2010
40-41 1 p. 1-2
2 p.
artikel
29 Editorial Advisory Board Klein, Eva
2003
40-41 1 p. CO2-
1 p.
artikel
30 Editorial Board 2008
40-41 1 p. CO2-
1 p.
artikel
31 Editorial Board 2010
40-41 1 p. CO2-
1 p.
artikel
32 Editorial Board 2009
40-41 1 p. CO2-
1 p.
artikel
33 Editorial Board 2013
40-41 1 p. CO2-
1 p.
artikel
34 Editorial Board 2011
40-41 1 p. CO2-
1 p.
artikel
35 Editorial Board 2012
40-41 1 p. CO2-
1 p.
artikel
36 Erratum to “BRCA1 methylation: a significant role in tumour development?” [Seminars in Cancer Biology 12 (2002) 359–371] Catteau, A.
2003
40-41 1 p. 91-
1 p.
artikel
37 Escape from immune- and nonimmune-mediated tumor surveillance Malmberg, Karl-Johan
2006
40-41 1 p. 16-31
16 p.
artikel
38 Family studies and the evidence for genetic susceptibility to prostate cancer Bishop, D.Timothy
1997
40-41 1 p. 45-51
7 p.
artikel
39 Focal adhesion kinase as a regulator of cell tension in the progression of cancer Tilghman, Robert W.
2008
40-41 1 p. 45-52
8 p.
artikel
40 Formation of non-random extrachromosomal elements during development, differentiation and oncogenesis Kuttler, Fabien
2007
40-41 1 p. 56-64
9 p.
artikel
41 Gene fusions encoding chimaeric transcription factors in solid tumours Sorensen, Poul H.B.
1996
40-41 1 p. 3-14
12 p.
artikel
42 Gene signatures in hepatocellular carcinoma (HCC) Andrisani, Ourania M.
2011
40-41 1 p. 4-9
6 p.
artikel
43 Gene therapy for prostate cancer Bower, Mark
1997
40-41 1 p. 3-9
7 p.
artikel
44 Genetically modulating T-cell function to target cancer Merhavi-Shoham, Efrat
2012
40-41 1 p. 14-22
9 p.
artikel
45 Genetic predisposition to cancer—issues to consider Malkin, David
1996
40-41 1 p. 49-53
5 p.
artikel
46 Genomic imprinting in tumours Squire, Jeremy
1996
40-41 1 p. 41-47
7 p.
artikel
47 Genomic mechanisms and measurement of structural and numerical instability in cancer cells Bayani, Jane
2007
40-41 1 p. 5-18
14 p.
artikel
48 Genomics and epigenomics of renal cell carcinoma Maher, Eamonn R.
2013
40-41 1 p. 10-17
8 p.
artikel
49 Genomic stability and tumorigenesis Sieber, Oliver
2005
40-41 1 p. 61-66
6 p.
artikel
50 H2-antagonists in the treatment of colon and breast cancer Bolton, Elaine
2000
40-41 1 p. 3-10
8 p.
artikel
51 Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapy Mathupala, Saroj P.
2009
40-41 1 p. 17-24
8 p.
artikel
52 H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells Radvány, Zsuzsa
2000
40-41 1 p. 41-45
5 p.
artikel
53 Histamine as an autocrine growth factor: an unusual role for a widespread mediator Rivera, Elena S.
2000
40-41 1 p. 15-23
9 p.
artikel
54 Histamine in brain development and tumors Panula, Pertti
2000
40-41 1 p. 11-14
4 p.
artikel
55 HLA class I antigen abnormalities and immune escape by malignant cells Seliger, Barbara
2002
40-41 1 p. 3-13
11 p.
artikel
56 HLA-G and HLA-C at the feto–maternal interface: lessons learned from pathogenic viruses Schust, Danny J.
1999
40-41 1 p. 37-46
10 p.
artikel
57 HLA-G: a new opening for HLA Dausset, J.
1999
40-41 1 p. 1-
1 p.
artikel
58 HLA-G expression: immune privilege for tumour cells? Cabestre, Francisco Adrian
1999
40-41 1 p. 27-36
10 p.
artikel
59 Homeostatic functions of the p53 tumor suppressor: Regulation of energy metabolism and antioxidant defense Olovnikov, Ivan A.
2009
40-41 1 p. 32-41
10 p.
artikel
60 How do NK cells sense the expression of HLA-G class Ib molecules? López-Botet, Miguel
1999
40-41 1 p. 19-26
8 p.
artikel
61 Human papillomavirus-induced carcinogenesis and the ubiquitin–proteasome system Scheffner, Martin
2003
40-41 1 p. 59-67
9 p.
artikel
62 Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer Wang, Rong-Fu
2006
40-41 1 p. 73-79
7 p.
artikel
63 Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention Whiteside, Theresa L.
2006
40-41 1 p. 3-15
13 p.
artikel
64 Immunodominance and tumor escape Schreiber, H.
2002
40-41 1 p. 25-31
7 p.
artikel
65 Immunomodulating tellurium compounds as anti-cancer agents Sredni, Benjamin
2012
40-41 1 p. 60-69
10 p.
artikel
66 Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy Ruiz-Cabello, Francisco
2002
40-41 1 p. 15-24
10 p.
artikel
67 Implications of apoptotic cell death regulation in cancer therapy McDonnell, Timothy J.
1995
40-41 1 p. 53-60
8 p.
artikel
68 Induction of apoptosis by tumor suppressor genes and oncogenes Canman, Christine E.
1995
40-41 1 p. 17-25
9 p.
artikel
69 Induction of genes during apoptosis: examples from the immune system Osborne, Barbara A.
1995
40-41 1 p. 27-33
7 p.
artikel
70 Inflammation and immune surveillance in cancer Chow, Melvyn T.
2012
40-41 1 p. 23-32
10 p.
artikel
71 Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators Ben-Baruch, A.
2006
40-41 1 p. 38-52
15 p.
artikel
72 Interaction of histamine and other bioamines with cytochromes P450: implications for cell growth modulation and chemopotentiation by drugs LaBella, Frank S.
2000
40-41 1 p. 47-53
7 p.
artikel
73 Intracellular signaling and hepatocellular carcinoma Iakova, Polina
2011
40-41 1 p. 28-34
7 p.
artikel
74 Introduction Ferrone, Soldano
2002
40-41 1 p. 1-2
2 p.
artikel
75 Introduction Carbone, Michele
2001
40-41 1 p. 1-3
3 p.
artikel
76 Introduction and overview Ciechanover, A.
2003
40-41 1 p. 1-4
4 p.
artikel
77 Introduction: Apoptosis in oncogenesis and chemotherapy Eastman, Alan
1995
40-41 1 p. 1-
1 p.
artikel
78 Introduction: Basic science aspects of prostate cancer Waxman, Jonathan
1997
40-41 1 p. 1-
1 p.
artikel
79 Introduction: Genetic rearrangements in cancer Sheer, Denise
1996
40-41 1 p. 1-
1 p.
artikel
80 Involvement of polyamines in apoptosis. Facts and controversies: effectors or protectors? Schipper, Raymond G.
2000
40-41 1 p. 55-68
14 p.
artikel
81 Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis Robey, R. Brooks
2009
40-41 1 p. 25-31
7 p.
artikel
82 Kidney cancer Johansson, Martin E.
2013
40-41 1 p. 1-2
2 p.
artikel
83 Large common fragile site genes and cancer Smith, David I.
2007
40-41 1 p. 31-41
11 p.
artikel
84 Liver cancer epidemic in China: Past, present and future Chen, Jian Guo
2011
40-41 1 p. 59-69
11 p.
artikel
85 Mechanisms leading to chromosomal instability Gollin, Susanne M.
2005
40-41 1 p. 33-42
10 p.
artikel
86 Mechanisms leading to nonrandom, nonhomologous chromosomal translocations in leukemia Gollin, Susanne M.
2007
40-41 1 p. 74-79
6 p.
artikel
87 MicroRNAs and genomic instability Huppi, Konrad
2007
40-41 1 p. 65-73
9 p.
artikel
88 MicroRNAs and STAT interplay Kohanbash, Gary
2012
40-41 1 p. 70-75
6 p.
artikel
89 Microsatellite instability and DNA mismatch repair in human cancer Karran, Peter
1996
40-41 1 p. 15-24
10 p.
artikel
90 Mitochondria as targets for cancer chemotherapy Gogvadze, Vladimir
2009
40-41 1 p. 57-66
10 p.
artikel
91 Mitochondria in cancer: Not just innocent bystanders Frezza, Christian
2009
40-41 1 p. 4-11
8 p.
artikel
92 Mitochondrial dynamics and cancer Grandemange, Stéphanie
2009
40-41 1 p. 50-56
7 p.
artikel
93 Mitogen-activated protein kinases in hepatocellular carcinoma development Min, Lihua
2011
40-41 1 p. 10-20
11 p.
artikel
94 Modeling non-random deletions in cancer Kost-Alimova, Maria
2007
40-41 1 p. 19-30
12 p.
artikel
95 Modulating the p53 pathway Dey, Anwesha
2010
40-41 1 p. 3-9
7 p.
artikel
96 Molecular signature of hepatocellular carcinoma, hope or hype in prognosis and therapy Chen, Fei
2011
40-41 1 p. 1-3
3 p.
artikel
97 Monoclonal antibodies for the treatment of cancer Shuptrine, Casey W.
2012
40-41 1 p. 3-13
11 p.
artikel
98 Multiple numerical chromosome aberrations in cancer: what are their causes and what are their consequences? Teixeira, Manuel R.
2005
40-41 1 p. 3-12
10 p.
artikel
99 Mutations of the BRCA1 gene in human cancer Xu, Chun-Fang
1996
40-41 1 p. 33-40
8 p.
artikel
100 Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression Serafini, Paolo
2006
40-41 1 p. 53-65
13 p.
artikel
101 Natural killer cell-mediated recognition of human trophoblast Biassoni, Roberto
1999
40-41 1 p. 13-18
6 p.
artikel
102 Neoplastic “Black Ops”: Cancer's subversive tactics in overcoming host defenses Biragyn, Arya
2012
40-41 1 p. 50-59
10 p.
artikel
103 New approaches in identifying drugs to inactivate oncogene products Liu, Ruiwu
2004
40-41 1 p. 13-21
9 p.
artikel
104 NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach Amit, Sharon
2003
40-41 1 p. 15-28
14 p.
artikel
105 Non-random genomic instability in cancer: A fact, not an illusion Mai, Sabine
2007
40-41 1 p. 1-4
4 p.
artikel
106 Oncogenes as therapeutic targets Felsher, Dean W.
2004
40-41 1 p. 1-
1 p.
artikel
107 p53 family members in cancer diagnosis and treatment Machado-Silva, Alice
2010
40-41 1 p. 57-62
6 p.
artikel
108 Prospects for an SV40 vaccine Imperiale, Michael J
2001
40-41 1 p. 81-85
5 p.
artikel
109 Prostate cancer; the interface between pathology and basic scientific research Lalani, E.-N.
1997
40-41 1 p. 53-59
7 p.
artikel
110 Regulation of cancer cell metabolism by hypoxia-inducible factor 1 Semenza, Gregg L.
2009
40-41 1 p. 12-16
5 p.
artikel
111 Regulation of the Fanconi anemia pathway by monoubiquitination Gregory, Richard C.
2003
40-41 1 p. 77-82
6 p.
artikel
112 Renal stem cells and their implications for kidney cancer Axelson, Håkan
2013
40-41 1 p. 56-61
6 p.
artikel
113 Reorganisation of the dendritic actin network during cancer cell migration and invasion Vignjevic, Danijela
2008
40-41 1 p. 12-22
11 p.
artikel
114 RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer Fang, Shengyun
2003
40-41 1 p. 5-14
10 p.
artikel
115 Role of T antigen interactions with p53 in tumorigenesis Pipas, James M
2001
40-41 1 p. 23-30
8 p.
artikel
116 Simian virus 40 regulatory region structural diversity and the association of viral archetypal regulatory regions with human brain tumors Lednicky, John A.
2001
40-41 1 p. 39-47
9 p.
artikel
117 Small-molecule inhibitors of MDM2 as new anticancer therapeutics Dickens, Michael P.
2010
40-41 1 p. 10-18
9 p.
artikel
118 Spatial genome organization in the formation of chromosomal translocations Meaburn, Karen J.
2007
40-41 1 p. 80-90
11 p.
artikel
119 Specificity, selection and significance of gene amplifications in cancer Myllykangas, Samuel
2007
40-41 1 p. 42-55
14 p.
artikel
120 Strategies to circumvent SV40 oncoprotein expression in malignant pleural mesotheliomas Schrump, David S
2001
40-41 1 p. 73-80
8 p.
artikel
121 Strategies to overcome immune ignorance and tolerance Perales, Miguel-Angel
2002
40-41 1 p. 63-71
9 p.
artikel
122 Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis Eastman, Alan
1995
40-41 1 p. 45-52
8 p.
artikel
123 SV40 and cell cycle perturbations in malignant mesothelioma Testa, Joseph R.
2001
40-41 1 p. 31-38
8 p.
artikel
124 SV40 and the pathogenesis of mesothelioma Rizzo, Paola
2001
40-41 1 p. 63-71
9 p.
artikel
125 Targeted therapies in myeloid leukemia John, Alison M
2004
40-41 1 p. 41-62
22 p.
artikel
126 Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate Coutré, Steven
2004
40-41 1 p. 23-31
9 p.
artikel
127 Targeting stroma to treat cancers Engels, Boris
2012
40-41 1 p. 41-49
9 p.
artikel
128 ‘Targeting’ the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa®) in non-small cell lung cancer (NSCLC) Pao, William
2004
40-41 1 p. 33-40
8 p.
artikel
129 Targeting the ubiquitin–proteasome system to activate wild-type p53 for cancer therapy Allende-Vega, Nerea
2010
40-41 1 p. 29-39
11 p.
artikel
130 Targets for molecular therapy of skin cancer Green, Cheryl L
2004
40-41 1 p. 63-69
7 p.
artikel
131 T cell dysfunction in cancer: Role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress Rodríguez, Paulo C.
2006
40-41 1 p. 66-72
7 p.
artikel
132 The BCL-2 gene family Craig, Ruth W.
1995
40-41 1 p. 35-43
9 p.
artikel
133 The current clinical value of genomic instability Diaz Jr., Luis A.
2005
40-41 1 p. 67-71
5 p.
artikel
134 The discovery of nongenotoxic activators of p53: Building on a cell-based high-throughput screen McCarthy, Anna R.
2010
40-41 1 p. 40-45
6 p.
artikel
135 The evolutionary origin of genetic instability in cancer development Breivik, Jarle
2005
40-41 1 p. 51-60
10 p.
artikel
136 The genetic analysis of prostate carcinoma Roylance, Rebecca
1997
40-41 1 p. 37-44
8 p.
artikel
137 The immunotolerance role of HLA-G Rouas-Freiss, Nathalie
1999
40-41 1 p. 3-12
10 p.
artikel
138 The inflammation-cancer linkage: A double-edged sword? Baniyash, Michal
2006
40-41 1 p. 1-2
2 p.
artikel
139 The metabolic basis of kidney cancer Linehan, W. Marston
2013
40-41 1 p. 46-55
10 p.
artikel
140 The microfilament system and malignancy Lindberg, Uno
2008
40-41 1 p. 2-11
10 p.
artikel
141 The microfilament system in the formation of invasive adhesions Gimona, Mario
2008
40-41 1 p. 23-34
12 p.
artikel
142 The p53–Mdm2 module and the ubiquitin system Michael, Dan
2003
40-41 1 p. 49-58
10 p.
artikel
143 Therapeutic targeting of p53 by small molecules Selivanova, Galina
2010
40-41 1 p. 46-56
11 p.
artikel
144 The regulation of HLA class I expression: is HLA-G the odd one out? Gobin, Sam J.P.
1999
40-41 1 p. 55-59
5 p.
artikel
145 The regulation of MDM2 by multisite phosphorylation—Opportunities for molecular-based intervention to target tumours? Meek, David W.
2010
40-41 1 p. 19-28
10 p.
artikel
146 The role of peptide presentation in the physiological function of HLA-G Münz, Christian
1999
40-41 1 p. 47-54
8 p.
artikel
147 The role of the SV40 ST antigen in cell growth promotion and transformation Rundell, Kathleen
2001
40-41 1 p. 5-13
9 p.
artikel
148 The role of ubiquitylation in signaling by growth factors: implications to cancer Shtiegman, Keren
2003
40-41 1 p. 29-40
12 p.
artikel
149 The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets Yang, Ju Dong
2011
40-41 1 p. 35-43
9 p.
artikel
150 The ubiquitin/proteasome system in Epstein–Barr virus latency and associated malignancies Dantuma, Nico P.
2003
40-41 1 p. 69-76
8 p.
artikel
151 The VHL/HIF axis in clear cell renal carcinoma Shen, Chuan
2013
40-41 1 p. 18-25
8 p.
artikel
152 The von Hippel–Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis Pugh, Christopher William
2003
40-41 1 p. 83-89
7 p.
artikel
153 The Warburg Effect returns to the cancer stage Zhivotovsky, Boris
2009
40-41 1 p. 1-3
3 p.
artikel
154 Toll-like receptors, inflammation and cancer Tsan, Min-Fu
2006
40-41 1 p. 32-37
6 p.
artikel
155 Tropomyosins as interpreters of the signalling environment to regulate the local cytoskeleton O’Neill, G.M.
2008
40-41 1 p. 35-44
10 p.
artikel
156 Tumor cell recognition by natural killer cells Long, Eric O
2002
40-41 1 p. 57-61
5 p.
artikel
157 Tumor immunology—towards a paradigm of reciprocal research Drake, Charles G
2002
40-41 1 p. 73-80
8 p.
artikel
158 Tumor-induced death of immune cells: its mechanisms and consequences Whiteside, Theresa L
2002
40-41 1 p. 43-50
8 p.
artikel
159 Tumour escape from immune surveillance through dendritic cell inactivation Vicari, Alain P
2002
40-41 1 p. 33-42
10 p.
artikel
160 Tumour suppressor genes in prostate cancer MacGrogan, Donal
1997
40-41 1 p. 11-19
9 p.
artikel
161 Von Hippel–Lindau: How a rare disease illuminates cancer biology Richard, Stéphane
2013
40-41 1 p. 26-37
12 p.
artikel
162 Yet unrevealed aspects of histamine: questions from outside–answers at inside? László, Valéria
2000
40-41 1 p. 1-2
2 p.
artikel
163 Zhx2 and Zbtb20: Novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer Peterson, Martha L.
2011
40-41 1 p. 21-27
7 p.
artikel
                             163 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland